[由SGLT2抑制剂诱导的红细胞形成]
1Department of Hematology, Juntendo University School of Medicine.
概括
-葡萄糖共运输体2 (SGLT2) 抑制剂可以导致红细胞瘤,或增加红细胞. 这可能是由于液体转移或增加红素蛋白的产生,需要谨慎管理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 血液学 血液学 血液学
背景情况:
- -葡萄糖共运输体2 (SGLT2) 抑制剂用于糖尿病,心力衰竭和慢性病.
- 这些药物促进葡萄糖分泌,具有心脏和脏保护作用.
研究的目的:
- 调查SGLT2抑制剂诱导的红细胞增殖的新发现.
- 探索SGLT2抑制剂相关的红细胞瘤背后的潜在机制.
主要方法:
- 关于SGLT2抑制剂和红细胞瘤的最新发现的综述.
- 分析拟议的机制,包括流体体积变化和红色素的产生.
主要成果:
- SGLT2 抑制剂可以诱导红细胞增殖,这是红细胞症诊断的一个因素.
- 提出了两个机制:减少液体体积和增加红色素蛋白的产生.
结论:
- 红细胞瘤是SGLT2抑制剂的一种新副作用,需要考虑.
- discontinuation of SGLT2 抑制剂和瘤切除可能是必要的管理.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.2K
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
9.7K
相关概念视频
Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
Secondary Active Transport
6.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.6K
Glucose Absorption Into the Small Intestine
30.9K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
30.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones
140
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
140
Dipeptidyl Peptidase 4 Inhibitors
130
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
130
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
